Exam 4 Flashcards
Hydralazine and minoxidil MOA?
Opens K+ channels –> hyperpolarization of membrane and inhibition of calcium entry into smooth muscle –> Art VD –> (-) PVR AND (-) afterload pressure.
What are the Adverse Effects of sodium nitroprusside?
profound hypotension, Profound hypotension, reflex tachycardia. **Cyanide vs thiocyanate toxicity • Liver impairment (↑CN), or renal impairment (↑thiocyanate)
What are the Adverse Effects of hydralazine?
Reflex tachycardia, edema. Systemic lupus erythematosus-like syndrome- esp. in slow-acetylators
What are the Adverse Effects of minoxidil?
Reflex tachycardia, edema, more potent vasodilator. Therefore, it has the potential to precipitate angina and congestive heart failure.
Hirsutism.
PK of hydralazine?
t1/2 ~ 2-4 hrs.
PK of minoxidil?
Pro-drug - Activated by hepatic sulfotransferase.
last over 24 hrs (2-5 days).
What is the MOA of sodium nitroprusside?
vascular metabolism/ activation to NO by RBCs (heme) , NO then diffuses into the blood vessel ↑ cGMP –> smooth muscle relaxation, Opens K+ channels –> hyperpolarization and inhibition of calcium entry. Venous and Arterial Vasodilation)à Drop in Preload and Afterload
PK of sodium nitroprusside?
BP reduction < 2 minutes. Short-acting: Duration: 1-10 minutes.
Metabolism:
Blood Nitroprusside → cyanide (CN) ions. Liver CN → thiocyanate by rhodanase mitochondrial enzyme. Rate limiting step is the availability of thiosulfate donors. Kidney Thiocyanate slowly eliminated.
What is special about minoxidil?
Hirsutism.
What is special about sodium nitroprusside?
Methemoglobinemia, Photosensitive
What are the DHP CCBs?
Nicardipine, Nifedipine, Amlodipine
What is the MOA of DHPs?
Block L-type vg-calcium channels in arterial VSM –> (+) Ca2+ influx –> Arterial vasodilation
PK of nicardipine?
IV: 10 min.
PK nifedipine?
t1/2 = 2 hrs (IR). ER has biphasic peaks first at 2 hrs and at 6-12 hrs (ER).
PK of amlodipine?
Duration of action ~ 18-24 hrs; t1/2 = 30-50 hrs.
Adverse effects of DHPs?
Reflex tachycardia, edema and Hypotension.
DDIs of DHPs?
CYP 3A4 substrates, inhibitors / inducers.
What is special about nicardipine?
Indication: acute hypertensive crisis.
Has less negative inotropic effects than nifedipine.
What is special about nifedipine?
Short-acting is associated with an increased risk for MI or mortality. Long-acting CCB’s are preferred in chronic treatment of HTN.
What is special about amlodipine?
amlodipine is administered once daily in its standard formulation
(immediate release).
What are the Non-DHPs?
Verapamil, diltiazem
MOA of Non-DHPs?
inhibit calcium influx in myocardium and VSM.
Verapamil PK?
Metabolism: CYP 3A4 (N-demethylation) –> active (~20%) metabolite (norverapamil t1/2: 6-10 hrs).CYP 2D6 (O-demethylation) to inactive metabolite.
Diltiazem PK?
Deacetylation (major route) –> active metabolite (~25-50%). CYP 3A4 (N-demethylation) and CYP 2D6 (O- demethylation).
AEs of Non-DHPs?
Edema, Hypotension, HF, Arrhythmias, AV block, bradycardia.
DDIs of Non-DHPs?
CYP 2D6 & 3A4 substrates, inducers, inhibitors. an inhibitor of P-gp and CYP 3A4. inhibits Pgp efflux → ↑[digoxin] → digoxin toxicity (verapamil?).
Verapamil special?
Indication: atrial fibrillation, angina, HTN.
(Negative chronotrope, Moderate negative inotrope.
Can precipitate heart failure esp. in patients with limited cardiac reserve.
Special diltiazem?
Mild negative inotropic effects. Intermediate affinity to cardiac cells. safer than verapamil.
DDI barbituates and felodipine, nifedipine, and verapamil?
Decreased effects of CCBs
DDI Beta-blockers and CCBs?
Additive or synergistic (more verapamil and diltiazem); inhibition of beta-blocker metabolism
DDI cimetidine and CCBs?
Increased 1,4 DHP levels
DDI digoxin and nifedipine, diltiazem, and verapamil?
Increased digoxin levels
DDI HMG CoA reductase inhibitors and diltiazem, verapamil?
Increased levels of HMG CoA reductase inhibitors
DDI phenytoin and CCBs?
Decreased effectiveness of CCBs due to induction
DDI rifamin and diltiazem, nifedipine, nisoldipine, verapamil?
Decreased levels of CCB
Angiotensin II on blood vasculature?
Direct rapid vasoconstriction
Angiotensin II on kidneys?
Increased Na+ reabsorption, increased vasocontriction
Angiotensin II on heart?
Increased HR
MOA of ACE inhibitors?
Reversible inhibition of ACE.
(block angiotensin –> VD, No aldosterone releaseàno Na and Water retention, block hydrolysis of bradykinin).